1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6497AE38D5F9F69D285257C8D0074F826
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-strategic-kol-management-performance-measurement-staffing-and-success-factors?opendocument
18
19opendocument
203.80.4.76
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services ╗ Medical AffairsThought Leader Services

Strategic KOL Management: Performance Measurement, Staffing and Success Factors

ID: 5297


Features:

10 Info Graphics

9 Data Graphics

51 Metrics

4 Narratives


Pages/Slides: 25


Published: 2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Strategic KOL Management: Performance Measurement, Staffing and Success Factors"

STUDY OVERVIEW

While the evolving U.S. healthcare system is altering many aspects of the biopharmaceutical marketplace, the importance of Key Opinion Leaders (KOLs) remains unchanged. The influence of KOLs continues to extend from clinical programs and medical education to prescribing habits and payer access. Consequently, it's vital for biopharmaceutical organizations to effectively manage these important and often complex relationships through systems, processes, and procedures.


Best Practices, LLC conducted this research to help organizations create and maintain a strategic KOL management system. In particular, this study examines current approaches to performance measurement, staffing and success factors for a strategic KOL management system. This study provides an evidence-based understanding of current and evolving approaches to creating and maintaining an integrated, strategically-focused KOL management system.

KEY TOPICS

  • Measuring Strategic Thought Leader Management and Engagement Success
  • Staffing Strategic Thought Leader Management and Engagement
  • Looking Forward: Success Factors for Strategic TL Managementá& Engagement
KEY METRICS
  • How is strategic KOL management assessed within your company
  • How do you get feedback from KOLs regarding company interactions
  • What are the top three things KOLs value most from interactions
  • How much does your organization value day to day strategic KOL management
  • Number of non-field based FTEs involved in your strategic KOL management
  • Is there a clear career pathway for staff doing strategic KOL management
SAMPLE KEY FINDING
  • Participants clearly feel that their organization sees some value in the day-to-day strategic KOL management – almost half think their company highly values the work while the remainder of respondents think their company somewhat values the work.

METHODOLOGY

Thirty-four TL management leaders from 29 biopharma and device organizations participated in the external field survey, and we interviewed 4 participants for in-depth insights

Industries Profiled:
Health Care; Pharmaceutical; Biotech; Medical Device; Manufacturing; Education; Science; Biopharmaceutical; Clinical Research; Laboratories; Medical


Companies Profiled:
Abbott Nutrition; Abbvie; Amgen; Antibiotice; Astellas; Baxter Healthcare; Biogen Idec; Boehringer Ingelheim; Crescendo Bioscience; Cubist Pharmaceuticals; Eisai; Intermune; Janssen; Jazz Pharmaceuticals; Mallinckrodt; Marcyrl; Medtronic; Merck; MSD; Onyx Pharmaceuticals; Pierre Fabre Medicament; ProStrakan; Reliance Institute of Life Sciences; Roche; Sanofi; Sanofi Renal; Servier; Shire; TauRx Therapeutics; Janssen Biotech; Inc.; A.P. Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.